Nectero Medical

About:

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

Website: https://necteromedical.com

Top Investors: Alumni Ventures, Norwest Venture Partners, Boston Scientific, KOFA Healthcare, Aphelion Capital

Description:

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.

Total Funding Amount:

$116M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tempe, Arizona, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)necteromed.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-04-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai